Dr. JIANJUN (Jessie Zou) is Chief Medical Officer (CMO), Vice president of JIANGSU HENGRUI MEDICINE, CO. LTD. She was trained by medical oncology in China and got her medical doctor degree in the second military medical university. She had been working in the level 3 A hospital as a medical oncologist for 10 years from 1995 – 2005. Then she joined Bayer Healthcare pharmaceutical company in China. She had been leading the clinical development programs of Sorafenib in China as the clinical trial physician, head of oncology therapeutic team in Bayer China. Then she moved to NJ, USA and worked as the global medical lead of Xofigo in the global medical affairs team in BayerhealtherCare Headquarter. In 2012, she joined Celgene and worked as the director, head of the medical department, China. Starting from Sept 2015, she joined JIANGSU HENGRUI MEDICINE, CO. LTD as the Vice President and chief medical officer.
邹建军(Jessie Zou)博士是江苏恒瑞医药股份有限公司副总经理，首席医学官(CMO)，分管全球临床研发和医学事务（global clinical development and medical affairs），获得第二军医大学医学博士学位。从1995年到2005年，她作为一名肿瘤科医生在三级甲等医院工作了10年。之后，她加入了拜耳医药股份有限公司，曾作为临床试验医师、拜耳中国肿瘤治疗团队负责人领导索拉非尼在中国的临床研发项目。之后，她到美国新泽西州，在拜耳总部的全球医学事务团队担任Xofigo的全球医学事务总监。2012年加入新基医药，任中国医学事务负责人、总监。2015年9月起加入江苏恒瑞医药股份有限公司，担任副总经理、首席医学官。